Tiziana Life Sciences (NASDAQ:TLSA) Trading Down 3.7% – Here’s What Happened

Tiziana Life Sciences Ltd (NASDAQ:TLSA)’s share price was down 3.7% on Tuesday . The company traded as low as $0.91 and last traded at $0.91. Approximately 61,647 shares were traded during mid-day trading, a decline of 70% from the average daily volume of 208,430 shares. The stock had previously closed at $0.95.

Tiziana Life Sciences Stock Down 3.7 %

The business’s fifty day simple moving average is $0.95 and its two-hundred day simple moving average is $0.96.

Hedge Funds Weigh In On Tiziana Life Sciences

A hedge fund recently bought a new stake in Tiziana Life Sciences stock. Sanctuary Advisors LLC bought a new position in shares of Tiziana Life Sciences Ltd (NASDAQ:TLSA) in the third quarter, according to the company in its most recent filing with the SEC. The firm bought 907,613 shares of the company’s stock, valued at approximately $864,000. Sanctuary Advisors LLC owned approximately 0.86% of Tiziana Life Sciences as of its most recent SEC filing.

About Tiziana Life Sciences

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases.